Search for: "Pfizer, Inc."
Results 1201 - 1220
of 1,513
Sort by Relevance
|
Sort by Date
10 Mar 2009, 9:22 am
Pfizer Inc., March 4, 2009 For more information on FMLA leave or other employment-law matters, contact Lori Searcy at 703-644-4122. [read post]
9 Mar 2009, 9:52 pm
On the heels of Pfizer's $68 billion acquisition of Wyeth (see "Pfizer Expected to Announce Wyeth Acquisition on Monday") in January, Merck & Co., Inc. and Schering-Plough Corp. announced today that their Boards of Directors had unanimously approved a definitive merger agreement under which Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough stock and each share of Merck stock will become a… [read post]
9 Mar 2009, 7:24 pm
Wyeth Company may be extremely sensitive to this decision as rival pharmaceutical company Pfizer Inc. is expected to buy out Wyeth for $68 billion later this year. [read post]
6 Mar 2009, 2:42 pm
Pfizer, Inc., No. 07-1920 (4th Cir. [read post]
5 Mar 2009, 10:44 pm
The judge granted Pfizer, Inc. [read post]
4 Mar 2009, 4:00 am
Pfizer, Inc., Philadelphia Common Pleas Case No. 1819 (February 9, 2009) [Slip Opn., at 1]. [read post]
26 Feb 2009, 7:32 am
Medtronic now joins Eli Lilly & Co. and Pfizer Inc. in making these voluntary disclosures. [read post]
26 Feb 2009, 5:54 am
., Inc., Pfizer Inc. and Astellas Pharma Canada Inc. [read post]
26 Feb 2009, 3:52 am
"Eli Lilly & Co. and Pfizer Inc. have already volunteered to publish such information, and Medtronic said its decision was also voluntary. [read post]
19 Feb 2009, 12:55 am
., Nos. 07-4500 and 07-4564 (January 30, 2009).The securities class action against Pharmacia Corporation ("Pharmacia"), Pfizer, Inc. [read post]
17 Feb 2009, 6:53 am
The case involves a group of investors (collectively, the “Plaintiffs”) alleging that Pharmacia, Inc. and its acquirer, Pfizer, Inc., (collectively, the “Defendants”) violated §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 by making, with scienter, materially false statements about a clinical study of Celebrex. [read post]
12 Feb 2009, 9:55 am
(Bloomberg) -- Pfizer Inc. board member James Kilts sold 86 percent of his Pfizer shares about the same time the company began talks to buy Wyeth, according to a regulatory filing that says the transaction occurred without his knowledge.Kilts, 61, the former chief executive officer of Gillette Co., sold 13,905 Pfizer shares for $259,772 from June 3 to June 6, according to a U.S. [read post]
10 Feb 2009, 10:34 pm
Pfizer Inc. and Warner-Lambert Co., LLC, No. 1819, Control Nos. 061293/061291, Slip op. [read post]
10 Feb 2009, 4:47 pm
Pfizer Inc. and Warner-Lambert Co., LLC, No. 1819, Control Nos. 061293/061291, Slip op. [read post]
9 Feb 2009, 5:00 am
Pfizer, Inc., 2009 WL 214649 (2d Cir. 2009). [read post]
6 Feb 2009, 8:19 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition Petitioner's reply Brief amicus curiae of the Washington Legal Foundation (in support of petitioner) Brief amicus curiae of Pfizer, Inc. [read post]
5 Feb 2009, 12:19 pm
Pfizer, Inc., 381 F. [read post]
5 Feb 2009, 6:32 am
Well-known antidepressants include Eli Lilly and Co's (LLY.N) Prozac, Pfizer Inc's (PFE.N) Zoloft, GlaxoSmithKline Plc's (GSK.L)(GSK.N) Paxil and Forest Laboratories Inc's (FRX.N) Lexapro and Celexa. [read post]
3 Feb 2009, 4:23 am
Pfizer, Inc., Docket Nos. 05-4863-cv (L), 05-6768-cv (CON), slip op. (2d Cir. [read post]
3 Feb 2009, 1:40 am
JPMorgan Chase & Co., Bank of America Corp., Barclays Plc, Citigroup Inc. and Goldman Sachs Group Inc. assembled the loan package for Pfizer. [read post]
